CTRI/2022/07/044468
Completed
Phase 3
Evaluation of Efficacy and Safety of Namskar Ayurved’s Repair and Restore Moisturizing Body Oil in Healthy participants - An open label, non-comparative, interventional, prospective, clinical study - NI
amaskar Ayurved Private Limited0 sites33 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- amaskar Ayurved Private Limited
- Enrollment
- 33
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Clinically diagnosed mild to moderate skin dryness assessed using clinical grading score
- •2\.Willing to comply with all requirements of the study.
Exclusion Criteria
- •1\.Subjects with a known current history of chronic skin diseases or autoimmune diseases, such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo and rosacea
- •2\.Subjects with a tattoo, a scar, moles, too many hairs or anything on the Right leg which might interfere with the evaluation.
- •3\.Subjects with intensive exposure to sunlight or UV\-rays within the previous month and foreseen during the study.
- •4\.Subjects who have used facial blemish\-lightening products (such as products claiming to have whitening or blemish\-lightening effects), topical or oral whitening drugs. Moisturizing cream, lotion or oil within 21 days before entering the trial
- •5\.Subjects on any other investigational products within 1 month prior to randomization
- •6\.Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure, liver failure
- •7\.Pregnant and lactating women
- •8\.Known hypersensitivity to any of the ingredients of Namskar Ayurved’s Repair and Restore Moisturizing Body Oil
- •9\.Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Clinical study on Vetiver Concentrate for skin soothing activityCTRI/2022/09/045429amaskar Ayurved Private Limited36
Completed
Phase 3
Study of Ayurvedic formulation in Diabetic Kidney Disease.Health Condition 1: null- k/c/o/ Diabetic Kidney Disease. 3months k/c/o Type 2 DM at least since 6 months.Health Condition 2: E112- Type 2 diabetes mellitus with kidney complicationsHealth Condition 3: E112- Type 2 diabetes mellitus with kidney complicationsCTRI/2018/04/013063Dr Aparna Sathe99
Not yet recruiting
Phase 2
A clinical trial to study the effect of Kutajavaleha in Grahani RogaCTRI/2019/01/017277Central Council for Research in Ayurvedic Sciences New Delhi
Completed
Phase 2
Clinical trial of CIM-Meg19 in COVID-19 patientsCTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80
Not yet recruiting
Phase 2
Evaluation of Safety and Efficacy of a Herbo mineral Formulation for increasing Hemoglobin and Iron Deficiency AnaemiaHealth Condition 1: D509- Iron deficiency anemia, unspecifiedCTRI/2024/03/064617Dabur India Pvt Ltd